Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

Clinical trial NCT00816660 · COMPLETED

Trial details

NCT number: NCT00816660
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Von Willebrand Disease

Start date: 2008-12-01
Primary completion: 2010-08-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.